WHAT TO EXPECT
Gold Sponsor Servier is pleased to host their 2023 Early Innovation Award at LabCentral! This Golden Ticket will go to a startup who is driving scientific innovation in areas of high unmet need, including hard-to-treat diseases in oncology, neuroscience, and immuno-inflammation, as well as those pursuing research in translational medicine, drug development technologies, and drug delivery platforms. Come and network over fresh crêpes and pastries while supporting the competing companies!
Gold Sponsor Servier is pleased to host their 2023 Early Innovation Award at LabCentral! This Golden Ticket will go to a startup who is driving scientific innovation in areas of high unmet need, including hard-to-treat diseases in oncology, neuroscience, and immuno-inflammation, as well as those pursuing research in translational medicine, drug development technologies, and drug delivery platforms. Come and network over fresh crêpes and pastries while supporting the competing companies!
AGENDA
4:00 PM - Arrival & Registration
4:30 PM - Welcome remarks from Christophe Thurieau
4:35 PM - Fireside Chat with Deniz Razon and Walid Kamoun
4:55 PM - Contestant Pitching Begins
Judges: Pat Fetaya, Christophe Thurieau & Irene Blat
5:25 PM - Closing remarks & winners announced
5:30 PM - Networking
4:00 PM - Arrival & Registration
4:30 PM - Welcome remarks from Christophe Thurieau
4:35 PM - Fireside Chat with Deniz Razon and Walid Kamoun
4:55 PM - Contestant Pitching Begins
Judges: Pat Feya, Christophe Thurieau & Irene Blat
5:25 PM - Closing remarks & winners announced
5:30 PM - Networking
PITCHING COMPANIES
Hovana is focused on clinically enabling a pipeline of genomic medicines that target key molecular drivers of translational dysfunction in cancer.
Proteinea makes biotherapeutics design smarter, safer, and faster by leveraging novel deep-learning models & platforms integrated with smart experimental throughput.
Vrata Therapetuics is developing a humanized and optimized version of the anti-DNA 3E10 antibody, that is taken up by cells via a transporter called ENT2.
SPEAKERS
Deniz Razon
Chief Business Officer
Walid Kamoun
Global Head of R&D Oncology
JUDGES
Christophe Thurieau
Executive Director of Research
Pat Fetaya
Head of U.S. Business Development
Irene Blat
Sir. Director, S&E, Oncology
LOCATION
LabCentral Lobby
700 Main Street, Cambridge, MA